Contributors
Seventeen corporate and non-profit donors provide funding for OMOP through the Foundation for the National Institutes of Health, which manages the project.
Abbott
Amgen Inc.
AstraZeneca
Bayer Healthcare Pharmaceuticals, Inc.
Bristol-Myers Squibb
Eli Lilly & Company
GlaxoSmithKline
Johnson & Johnson
Lundbeck, Inc.
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Pfizer Inc
Pharmaceutical Research Manufacturers of America (PhRMA)
Roche
sanofi-aventis
Schering-Plough Corporation
Takeda